In this section

Clinical trials

Active clinical trials

Clinical Trials - Diseases by specialty group


Late Effects and Supportive Studies 6

    Protocol ID
  • Associated disease
    Title
    Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer
    Communication in the Early Pediatric Cancer Treatment Period
    SARCAT-QOL: Patient Reported Quality of Life After Treatment for Pediatric High-Risk Bone and Soft Tissue Sarcomas
    NYMC-579
  • Late Effects and Supportive Studies
    A Pilot Study in the Treatment of Refractory Adenovirus (AdV) Infection with Related Donor AdV Cytotoxic T-Lymphocytes (AdV-CTLs) in Children, Adolescents and Young Adult Recipients
    NYMC-580
  • Late Effects and Supportive Studies
    A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections with Related Donor CMV Specific Cytotoxic T-Cells (CTLs) in Children, Adolescents and Young Adult Recipients
    NYMC-581
  • Late Effects and Supportive Studies
    A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection with Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients
Contact us

For more information about cancer and blood disorders clinical trials, email us or call

(414) 955-4727

Get a second opinion

It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.

Why participate in clinical trials?

Michael Burke, MD

"The steady improvement in survival for children with cancer is a direct result of their enrollment onto clinical trials; without which we would remain decades behind in terms of scientific advances in pediatric cancer." ~Michael J. Burke, MD